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Abstract
Introduction: Xanthogranulomatous cholecystitis (XGC) is often mistaken for, and may predispose to,
gallbladder carcinoma (GB Ca). This study reviews the worldwide variation of the incidence, investiga-
tions, management and outcome of patients with XGC.
Methods: Data from 29 studies, cumulatively containing 1599 patients, were reviewed and results
summarized by geographical region (Europe, India, Far East and Americas) with 95% confidence intervals
(CIs) to present variability within regions. The main study outcomes were incidence, association with GB
Ca and treatment of patients with XGC.
Results: Overall, the incidence of XGC was 1.3–1.9%, with the exception of India where it was 8.8%.
The incidence of GB Ca associated with XGC was lowest in European studies (3.3%) varying from
5.1–5.9% in the remaining regions. Confusion with or undiagnosed GB Ca led to 10.2% of patients
receiving over or under treatment.
Conclusions: XGC is a global disease and is associated with GB Ca. Characteristic pathological,
radiological and clinical features are shared with GB Ca and contribute to considerable treatment
inaccuracy. Tissue sampling by pre-operative endoscopic ultrasound or intra-operative frozen section is
required to accurately diagnose gallbladder pathology and should be performed before any extensive
resection is performed.
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Introduction
Xanthogranulomatous cholecystitis (XGC) is an uncommon form
of cholecystitis1,2 which presents with non-specific symptoms and
signs, making it indistinguishable from typical acute or chronic
cholecystitis.3–5 XGC is traditionally a histopathological diagnosis
of focal or diffuse acute and chronic cholecystitis.Microscopically,
lipid containing histiocytes infiltrating into the outer layer of the
muscle lining the gall bladder wall may be seen to form xan-
thogranulomatous foci and fibrosis owing to extravasation of bile
into the gallbladder wall.6,7
XGC is frequently misdiagnosed as gallbladder carcinoma (GB
Ca) on presentation,8,9 ultrasound,10,11 computed tomography
(CT)12 and intra-operatively.8 This is confounded by reports that
GB Ca is more frequently associated with XGC than other forms
of cholecystitis.6,8,13–19 Rates of co-existing carcinoma vary from
2–15% of patients with XGC,8,20,21 suggesting a causal association.8
An incorrect diagnosis, which may be as high as 25%,3 results in
inappropriate surgery in the form of open exploration or gallblad-
der bed resection for GB Ca3,22,23 rather than simple laparoscopic
cholecystectomy for XGC or a missed diagnosis of GB Ca in
patients undergoing a laparoscopic cholecystectomy8,9 who
require open exploration or gallbladder bed resection. XGC also is
associated with an increased rate of conversion from laparoscopic
to open operative procedures5,9,24,25 owing to procedural difficulty
related to local inflammation creating dense adhesions9,26,27 or
gallbladder wall thickening.4
A pre-operative ultrasound and CT in patients with XGC may
display specific features which are suggestive of XGC. These
include the presence of intramural echogenic nodules,1,4,10,28,29 see
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Fig. 1, a ‘halo sign’ (a hypodense curvilinear band),1,4,10,15,29 intra-
hepatic duct dilatation30 and a loss of interface between the gall-
bladder and the liver.4,7,11,31–34 Although these features are also seen
in GB Ca, visualization of a continuous mucosal line,4,9,14,34,35 see
Figs 1, 2 and 3, and the absence pericholecystic fluid,34 shown in
Fig. 3, which both suggest a diagnosis of XGC rather than GB Ca,
may be then used to differentiate between XGC and GB Ca.
Although these features have been demonstrated to be effective at
detecting XGC and differentiating XGC from GB Ca it is unclear,
to date, how frequently these features are reported in routine
clinical practice.
The incidence of GB Ca is higher in Indian and Far Eastern
populations than in Western populations.36 As there are a greater
number of studies originating from Indian and Far Eastern groups
there may also be geographical variation in the incidence, treat-
ment and outcomes of patients with XGC. The aim of this study
was to identify the incidence of XGC within a European cohort of
patients and to pool these data with published studies to explore
geographical variation in rates of XGC and associated GB Ca with
the intention of providing the most accurate indication of the true
incidence of XGC, its association with GB Ca and outcomes. Sec-
ondary outcomes of the study aim to review the proportion of
patientswho receive correct treatment and the findings and report-
ing frequency of radiographical investigations for XGC andGBCa.
Methods
This study was a retrospective study of all patients who underwent
a cholecystectomy at St James’s University Hospital (SJUH),
Leeds, United Kingdom, from June 2005 to December 2010.
Patients were identified from the department of pathology data-
base and those with XGC selected for detailed review. Patient
notes were reviewed to obtain the presenting signs and symptoms,
patient demographic variables, findings at radiological interven-
tion (mucosal line continuity, nodule echogenicity, halo sign,
visible loss of interface between the gallbladder and liver, peric-
holecystic fluid and hepatic duct dilation), the planned and actual
operation type, complications, if GB Ca was suspected and his-
topathological data (gall stones, gallbladder thickening, gallblad-
der fibrosis and the presence of GB Ca).
Pooling data with other studies
Previously published studies were identified by review of PubMed,
Medline, the Cochrane Library and Embase using the search terms
‘xanthogranulomatous cholecystitis’ and ‘fibroxanthogranuloma-
tous fibrosis’ (Fig. 4). The reference lists of these studies were
searched to identify further studies of relevance. Case reports and
case series containing five or less patients with XGC were excluded
from review. Of 31 suitable studies, three were excluded as the full
paper was not able to be accessed16,20,37 leaving 29 cohorts, includ-
ing the present study, for review. Included studies (Table 1) were
reviewed for patient demographics, investigative findings, man-
agement, operative findings and outcomes, histopathological
details of the excised gallbladder, operative complications and the
incidence of XGC in the local population. The diagnostic accuracy
was also calculated for each study as [1 – (number of missed GB
Ca cases + number inappropriate extended resections performed
for incorrectly suspected GB Ca)/ total number of XGC patients]
¥ 100. Studies that reported pre-operative radiological findings
were recorded.
Figure 1 Imaging from patients with xanthogranulomatous cholecystitis (XGC). (a) An ultrasound scan demonstrating diffuse wall thickening
(cursor) and intramural echogenic nodules (arrow). (b) Computed tomography (CT) post contrast image demonstrating continuous enhance-
ment of the mucosal wall (small arrows)
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Studies were grouped into geographical location of the report-
ing institution: European (n = 7), Americas (n = 4), Far Eastern
(n = 10) and Indian (n = 8), to permit comparison among geo-
graphical regions.
Amedical statistician (J.H.) provided advice regarding statistical
interpretation and preparation of graphical comparison of the
reported incidence of: XGC amongst all resected gallbladders,
associated gall stones or GB Ca, gender of patients with XGC and
the age of patients with XGC. Data for each of the outcomes
consideredwere collected from each of the reported studies.Where
possible, 95% confidence intervals (CIs) were produced to give an
indication of the degree of variability in the data. The studies
within each geographical group were then combined to produce
pooled estimates of each outcome, which were also plotted.
Figure 2 Computed tomography (CT) scans from patients with biopsy-proven gall bladder cancer. (a) Circumferential enhancement of the
mucosa with focal wall thickening (small arrows). (b) Circumferential enhancement of the mucosa with focal thickening (small arrow) and
breach of the mucosa (arrowheads) with invasion into segment 4b of the liver (contrast with the figure showing XGC)
Figure 3 Magnetic resonance imaging demonstrating features of xanthogranulomatous cholecystitis (XGC). (a) A T2 weighted magnetic
resonance image (MRI) demonstrating fluid within the wall of the gall bladder (large arrow). (b) A T1 weighted MRI demonstrating continuous
enhancement of the mucosal line (small arrows)
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Results
Present study cohort
Of the 4773 cholecystectomies performed at SJUH during the
study period, 42 (0.9%) were diagnosed as XGC on pathological
review; there were no patients with XGC associated with GB Ca.
The mean (standard deviation) age of patients was 63 years
(10.1). Eighteen patients were male. Data detailing presenting
features, investigations, treatment, pathological findings and out-
comes are given in Table 2. No patients had a pre-operative diag-
nosis of XGC. Five patients were suspected to have GB Ca on the
basis of findings on at least one radiologicalmodality.After further
investigation, two patients were treated with a laparoscopic chole-
cystectomy only. One patient with suspected GB Ca underwent a
staging laparoscopy followed by a planned gallbladder bed resec-
tion and lymphadenectomy but at open operation no cancer was
observed and an open cholecystectomy was performed. In two
further patients, both undergoing a hepatectomy for colorectal
liver metastases, early GB Ca was suspected owing to macroscopic
features and the gallbladder bed was included within the resection.
Treatment inaccuracy in this cohort was therefore 3/42.
Review of published studies
Epidemiology
The pooled epidemiological and demographic data of the studies
are displayed in Table S1. Of the 42 719 cholecystectomies per-
formed in studies which reported the incidence of XGC (n = 19),
1321 patients (3.1%) were found to have XGC. There appeared to
be a higher incidence of XGC in Indian patients (780 of 8913
gallbladders, 8.8%) but a comparable incidence among European,
Americas or Far Eastern cohorts (1.3%, 1.5% and 1.9%, respec-
tively, Fig. 5a). There was little variation in patient gender among
regions (Fig. 5b). The mean age of all patients for whom data
was available (n = 1458) was 53.1 years.2–7,9,15,22,25,26,30–32,34,35,38–44
The mean age varied from 48.7 to 62.4 years among regions
(Fig. 5c).1–7,9,15,22,25,26,30–32,38,40–44
Pre-operative symptoms and signs
In studies reporting pre-operative symptoms and signs, the most
common symptom was abdominal pain which affected 906 of
1071 patients (84.6%);2,5,9,22,26,31,32,34,40,44 nausea affected 42/164
patients (25.6%);1–3,7,9,26 vomiting affected 34/152 patients
(22.4%);2,3,7,9,26 recent weight loss in 10/112 patients (8.9%);
and9,15,34 anorexia in 23/128 patients (18%).2,9,34,45 The most
common associated clinical feature was a positive Murphy’s sign,
present in 70/132 patients (53%);2–4,9 jaundice was present in 106/
517 patients (20.5%)1,3,5,7,9,15,22,25,26,29,34,38,40 and a right upper quad-
rant mass was noted in 37/389 patients (9.5%).1–3,5,15,25,34,38 GB Ca
was suspected in 190/1195 (15.8%) patients overall (range of 12.1
to 21.8% among regions)1–5,7,15,24,25,32,35,38,40,44 and this study
(Table S1).
Pathological data
Within the studies reporting pathological data, gall stones
were present in 1176/1366 (86.1%; 69 to 95.9% among
regions) (Fig. 5d).1–7,9,15,22,25,30–32,34,38,40–42,44,45 Owing to wide
variation reported within geographical regions it was not possible
to identify whether there was a significant effect among
geographical regions. The incidence of GB Ca coexisting with
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Figure 4 A summary of the search strategy in this review
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XGC was observed in 0–20% of patients among all
studies.1–7,9,15,22,24–26,31,32,34,35,38,40,44–46 Eleven of 23 studies, represent-
ing 326 patients, reported no patients with XGC and GB
Ca1,2,7,9,24,32,35,39,45 and this study. The pooled incidence of coexisting
GB Ca with XGC across all geographical regions was 75/1449
(5.2%; 3.3 to 5.9% among regions).1–7,9,15,22,24–26,31,32,34,35,38,40,44–46
There was greater variation within, rather than among, regions
suggesting reporting bias or local influence instead of geographi-
cal variation (Fig. 5e). A grossly thickened GB wall was commonly
observed, 974/1209 (80.6%) patients, regardless of the geographi-
cal region.1–5,7,9,15,25,26,30–32,34,44,45 A coexisting fistula between the GB
and adjacent organ was present in 108/1099 (9.8%; 1.1 to 12.1%
among regions) (Table S1).3–5,7,9,15,22,25,26,31,38,44
Surgical data
The accuracy of performing the correct operation, calculated
for 11 studies (determined by the frequency of missed GB Ca
and incorrect diagnosis of GB Ca), was 338/376 patients
(89.9%).3,4,9,15,22,25,26,35,45,46 Of the 38 patients receiving the incor-
rect treatment, 33 patients (8.8%) received an unnecessary
extended operation for incorrectly suspected GB Ca and 5
patients (1.3%) were treated with a cholecystectomy only and
were post-operatively diagnosed with GB Ca. There was little
variation in the accuracy among geographical regions (Table S1).
There was insufficient data in published studies to calculate the
accuracy for studies from the Americas. There was wide varia-
tion in the proportion of patients for whom treatment was
attempted laparoscopically, being lowest in India and the Ameri-
cas (33.3 and 22.5%, respectively) and highest in Europe and the
Far East (74.3% and 79.7%, respectively).4,5,9,22,25,26,38 The conver-
sion rate from a laparoscopic to open cholecystectomy varied
widely being lowest in Europe and the Far East but approxi-
mately three to four times greater in the Americas and
India (Table S1). The proportion of patients who developed
Table 1 A summary of the published case series included in the dataset of this study
Year Author Country of origin Group N with XGC Reference
1981 Goodman et al. USA Americas 40 11
2004 Valdivia et al. Mexico Americas 182 5
2008 Srivastava et al. USA Americas 11 70
2010 Goshhima et al. USA Americas 18 29
1987 Roberts et al. UK Europe 13 34
1994 Houston et al. UK Europe 31 14
1996 Casas et al. Spain Europe 12 1
2000 Parra et al. Spain Europe 26 4
2003 Karabulut et al. Turkey Europe 12 40
2007 Srinivas et al. UK Europe 29 24
2013 Hale et al. UK Europe 42 Present study
1987 Hanada et al. Japan Far East 23 31
1999 Mori et al. Japan Far East 45 71
1999 Kim et al. Korea Far East 19 30
2004 Kwon et al. Japan Far East 27 21
2007 Yang et al. China Far East 33 3
2007 Kwon et al. Japan Far East 60 72
2007 Sawada et al. Japan Far East 24 73
2009 Uchiyama et al. Japan Far East 32 7
2010 Mekky et al. Japan Far East 6 68
2010 Chang et al. South Korea Far East 49 33
1998 Dixit et al. India India 41 2
2004 Srikanth et al. India India 29 23
2008 Kansakar et al. India India 33 25
2008 Kumar et al. India India 620 41
2009 Kapoor et al. India India 34 63
2010 Agrawal et al. India India 42 74
2010 Jayalekshmi et al. India India 9 75
2010 Rastogi et al. India India 57 35
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post-operative complications varied from 4.9% to 20.1% among
regions.
Radiological features of XGC
The presence of intramural nodules/bands was reported in six
studies (four of which reported the echogenicity of these
nodules),4,9,29–31,34 the halo sign in three studies,1,4,32 the interface
between the gallbladder and liver in three studies,1,30,31 perichole-
cysticfluid infive studies,1,15,25,31,38 intra-hepaticductdilation in three
studies4,30,31 and mucosal line continuity in five studies.9,30,31,34,45
Discussion
XGC remains a poorly understood condition and patients risk
being over or under treated as a result of confusion with, or the
masking of, GB Ca.3 Associated fistulae to adjacent organs and
chronic inflammation contribute to the high rate of conversion of
laparoscopic into open procedures9 and post-operative complica-
tions.4,7 In spite of its importance, however, the true incidence of
XGC is still largely unknown with a wide variation reported in the
literature.47,48 In addition, although characteristic features on
radiological investigation have been shown to be indicative of XGC
ordiscriminative betweenXGCandGBCa,1,4 these are infrequently
reported on in clinical practice. This study presents the largest
European series to date together with all previously published
series in order to gain a worldwide perspective of XGC aiming to
identify geographical differences in presentation or management.
The most frequent clinical presentation of patients in the
pooled cohort was non-specific abdominal pain followed by other
symptoms and signs typical of cholecystitis demonstrating that
XGC is typically indistinguishable from cholecystitis on clinical
assessment.3–5 Gall stones are strongly associated with XGC but are
not present in every patient, indicating a role for additional aetio-
logical factors. In the SJUH study, 33 of 42 patients had associated
with gall stones, fewer than in previously published European
studies which have reported between 92% to 100%.4,38 The preva-
lence of inflammatory adhesions, fistulae to adjacent organs and
post-operative infection rates, which are higher than would be
expected after a routine cholecystectomy, reflects the chronic
inflammatory nature of this condition. For these reasons a high
proportion of laparoscopic operations are converted to an open
procedure.3,9,17,26
This study suggests there may be a geographical influence upon
the incidence of XGC with rates being approximately three to four
times greater in India than in other geographical regions. This has
been hypothesized to be because of the increased incidence of gall
stones in India44 which was also observed in this study. Gall stones
are believed to be causative of XGC owing to causing obstruction
of the cystic duct, biliary stasis and gall bladder mucosa ulcera-
tion, all of which facilitate local inflammation and extravasation
of bile into the gallbladder wall.2,5 There was, however, a wide
reported incidence within studies from both the Far East and
India. The studies with the smallest number of patients undergo-
ing a cholecystectomy tended to be those reporting the highest
incidence of XGC. This suggests there may be reporting bias.
However, the largest study from India reviewed 6150 gallbladder
specimens in which 620 gallbladders (10.1%) demonstrated XGC,
supporting this association. The male-to-female ratio appears to
be equal with little geographical influence. A cholecystectomy is
most commonly performed in females;49 in 2010–11 43 757 of
58 769 (74.5%) patients undergoing a cholecystectomy in the
United Kingdomwere female.50 Thus gender does not appear to be
a risk factor for XGC while female gender is for biliary colic and
uncomplicated cholecystitis.
Table 2 Pre-operative data, investigations, treatment and outcome
of the present cohort
N
Presenting feature Generalized abdominal pain 28
N = 32a Right upper quadrant pain 23
Nausea 9
Vomiting 11
Fever 7
Jaundice 6
Weight Loss 4
Anorexia 3
Murphy's sign 3
Right upper quadrant mass 1
Incidental finding at laparotomy 2
Investigation: USS Suspected cancer 4
N = 35b Nodule echogenicity reported 2
Intramural nodules/bands reported 1
Halo sign reported 0
Investigation: CT Suspected cancer 1
N = 16b Loss of interface between GB and
liver
2
Pericholecystic fluid 11
Intra-hepatic duct dilation 9
Pathology Carcinoma or dysplasia 0
N = 42 Gallbladder fibrosis 25
Gallbladder thickening 30
Gall stones 33
Choledocholithiasis 6
Fistula 4
Intervention
N = 42
Laparoscopic procedure
(converted to open)
36 (7)
Planned open cholecystectomy 2
Gallbladder bed resection 2
Complications
N = 42
Wound infection 4
a10 sets of patients emergency admission records were incomplete or
missing.
bEvery patient received either an USS or CT but not every patient
received both.
CT, computed tomography; USS, ultrasound scan; GB, gall bladder.
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Figure 5 (a) Incidence of xanthogranulomatous cholecystitis (XGC) in resected gallbladders. (b) Proportion of XGC patients that are male.
(c) Mean ages of XGC patients. (d) Proportion of XGC patients with gall stones. (e) Proportion of XGC patients with coexisting cancer. The
circle represents the mean value for each study, the horizontal bars represent 95% confidence intervals for each study and the diamond
represents the pooled data for all studies in each geographical region
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Several previous authors have suggested an association between
XGC and GB Ca.6,8,13–19 The incidence of GB Ca concurrent with
XGC displayed little geographical variation, being present in 5.2%
of XGC patients in the pooled cohort. This is higher than the
reported incidence of GB Ca within cholecystectomy specimens
which does vary according to geographical location and has been
reported as being: in Europe 0.09 to 1.1% of patients,51–55 in India
0.59 to 1.9%56–61 and in the Far East as 0.3 to 4.7%.62–69 Gall stones
were present in the majority of patients with XGC but not in every
patient suggesting a causal role together with other as yet uniden-
tified factors. The variation in incidence among regions is difficult
to interpret owing to wide variation amongst studies within the
same region. The mechanism of a relationship between XGC and
GB Ca remains unclear, however, a higher incidence of loss of
heterozygosity (LOH) of the fragile histadine triad (FHIT)
tumour suppressor gene in XGC compared with chronic chole-
cystitis implicates a genetic basis for XGC and a link with GB Ca
(in which LOH was not significantly greater than in XGC).70 The
presence of the association of XGC with GB Ca within each popu-
lation subgroup indicates this association may be irrespective of
the genetic and environmental variation in XGC among the dif-
ferent geographical populations studied.
XGC, or rather its association, with GB Ca is responsible for
approximately 1 in 10 patients being either over-treated with
unnecessary major surgery or under-treated for missed GB Ca.
Identifying diagnostic radiological features of XGC is therefore
desirable to avoid unnecessary morbidity. However, many of the
characteristic features of XGC demonstrated by radiological
investigation are shared with GB Ca.4,9,14,34,35 It has been suggested
that the different frequency of these features between XGC and
GB Ca can be used to differentiate the two pathological enti-
ties.30,34 For example, focal GB wall thickening favours GB Ca
while diffuse thickening favours XGC.34 Early GB wall enhance-
ment, loss of a continuous mucosal line and the absence of gall
stones similarly favour GB Ca.34 Although the proportion of
patients displaying these features is significantly different among
those with XGC and GB Ca they are not diagnostic. Reliance upon
these characteristics to decide upon treatment may result in
patients continuing to receive under or over treatment. Endo-
scopic ultrasound (EUS) can identify hyperechoic nodules asso-
ciated with XGC but loss of structure of the multilayered GB wall
and local infiltration seen at EUS are also features common with
GB Ca.28 It has been suggested that fluorine-18 fluorodeoxyglu-
cose positron emission tomography (FDG-PET) may be effective
in diagnosing GB Ca,71–73 however, FDG-PET for GB lesions
should be interpreted with caution owing to the inflammatory
nature of XGC which is likely to yield a false-positive result.74 One
patient in the present cohort had a false-positive FDG-PET result
suggesting GB Ca. Thus, on radiological imaging alone, differen-
tiating GB Ca from XGC with a high degree of accuracy is not
possible. Targeted tissue sampling at EUS, however, has been
shown to identify GB Ca with 93% accuracy in a study of patients
with suspected XGC and/or GB Ca.45 Although it is not possible to
compare the diagnostic accuracy of patients who were and were
not treated with EUS, owing to the data being obtained from
different patient cohorts, EUS provides a clear advantage in that it
permits assessment of targeted material. Owing to the rarity of
both XGC and GB Ca, the cost of performing EUS on patients in
whom the diagnosis is uncertain would be small. The increased
use of intra-operative frozen section analysis, which is the most
effective method of diagnosing XGC,20,75 will also prevent unnec-
essary extended resections from being performed on XGC
patients. A radical cholecystectomy with resection of the liver bed
and lymphadenectomy without bile duct resection or hepaticoje-
junostomy appears to have a slightly greater mortality than open
cholecystectomy alone.76,77 The risk of a radical cholecystectomy,
however, may be offset by this procedure carrying a lower risk of
potentially spilling bile in a patient with GB Ca than an open
cholecystectomy alone, which significantly reduces survival in
these patients.78 Therefore, in cases of uncertainty a hepatopan-
creatobiliary surgeon should resect the GB bed and send an intact
GB for pathological assessment. If a non-HPB surgeon encounters
a case of suspected GB Ca they should abandon the procedure
before mobilization or request the attendance of a HPB surgeon.
The advised management of cases is detailed in Fig. 6.
This study also demonstrated that patients with XGC exhibit a
greater rate of post-operative complications than those undergo-
ing a routine cholecystectomy without XGC49 in all geographical
regions, although this is lower in the Americas for reasons which
are unclear. This may reflect the presence of chronic inflammation
and high rates of open procedures. In the majority of studies the
nature of post-operative complications were not defined high-
lighting the importance of adopting standard definitions and
reporting of common clinical complications.
The major limitation of this study was that the completeness of
the dataset is subject to the reporting quality of the included
studies.Additionally, as this study was unable to access the original
data it was not possible to perform statistical significance testing
among different geographical groups.
Conclusion
This study has demonstrated that XGC is a difficult condition to
diagnose pre-operatively and that confusion between XGC and
GB Ca results in incorrect treatment for over 1 in 10 patients with
XGC. The association of XGC with an increased rate of GB Ca is
highly likely within European, American, far Eastern and Indian
populations. It is the recommendation of this study that charac-
teristic features seen at radiological intervention be used to alert
clinicians to the possibility of XGC. These radiological findings
cannot be relied upon to accurately diagnose XGC or exclude
coexisting GB Ca, however, and thus pre-operative investigation
with EUS and tissue sampling is also required. Intra-operative
frozen section analysis should be considered mandatory in
patients with suspected GB Ca to permit accurate operative
interventions.
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• Loss of structure of multi-layered GB wall
• Local infiltration
Normal or features of XGC only:
• Hyper-echoic nodules
Treat with laparoscopic 
cholecystectomy with intra-
operative frozen section
Treat with laparoscopic
cholecystectomy
Treat with laparoscopic 
cholecystectomy with intra-
operative frozen section
Radical cholecystectomy 
with resection of liver 
segments 4b/5 and 
lymphadenectomy
Yes
No
Figure 6 A suggested treatment pathway for patients with ultrasounds features suggesting XGC or GB Ca.
CT: computed tomography scan; GB Ca: gall bladder carcinoma; GB: gall bladder; USS: ultrasounds scan; XGC: xanthogranulomatous
cholecystitis
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